Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income

Enrolling by invitation · Not applicable

Conditions studied: Monitoring Blood Pressure, Aspirin Prophylaxis

In brief

The goal of this clinical trial is to learn if a telehealth hypertension group prenatal care program (Centering HER / HGPC-T) can improve blood pressure monitoring and aspirin adherence and help reduce early-onset preeclampsia in low-income, predominantly Black pregnant participants in Kansas who are \<13 weeks gestation, age ≥18, and moderate or high risk for preeclampsia (USPSTF). The main question\[s\] it aims to answer \[is/are\]: Does Centering HER increase hypertension monitoring and aspirin compliance compared with usual doula care? Is Centering HER feasible and acceptable, and what contextual factors influence implementation in community clinics?

Key facts

Study ID

NCT07491510

Run by

University of Kansas Medical Center

People needed

36

Starts

2026-03-02

Expected to finish

2026-10-30

Last updated by the study team

2026-07-07

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• English or Spanish speaking
• <13 weeks gestations
• >18 years old
• moderate or high risk for hypertensive disorders in pregnancy

You may not qualify if…

• less than18 years of age
• not receiving prenatal care
• not eligible for doula care
• no risk factors for hypertensive disorders in pregnancy

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.